You are here: Info > Legislation > Greek Pharmacovigilance Legislation

Greek Pharmacovigilance Legislation

National Organization for Medicines Circular 67585 26-09-2011

Electronic reporting requirements for Suspected Unexpected Serious Adverse Reactions (SUSAR) from interventional clinical trials and for spontaneous reports, reports from non-interventional studies or others, including requirements for submission of literature articles to the National Organization for Medicines.

[Original text: EN GR]

 

 



Back To Greek Pharmacovigilance Legislation